Child Stunting Risks Threaten South Africa’s 2030 Goals
South Africa must address critical child stunting risks to meet its 2030 health targets, as experts warn of municipal service failures.
mRNA Vaccines Show Promise in Personalised Therapy
Uncover the potential of mRNA vaccines that show promise for personalized cancer treatments that target tumor cells effectively.
Imported Medicines Threaten SA’s Local Pharmaceutical Industry
Learn how reliance on imported medicines threatens South Africa’s jobs and the industry’s pharmaceutical security.
Surge in Malaria as Climate Change Fuels Regional Outbreaks
Malaria cases surge despite efforts to eliminate the disease. Discover the impact of weather conditions on this worrying trend.
Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
Daraxonrasib Pancreatic Cancer Pill Doubles Survival
Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.
Medical Scheme Financial Pressure Escalates As Costs Soar
Medical scheme financial pressure intensifies as healthcare costs, an ageing population, and a R11.64bn operating deficit squeeze the sector.
Excessive Dialysis Product Pricing: Adcock Ingram Referred
The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts.
Workplace Mental Health: From Apps To System Change
Learn about workplace mental health and the pressing need for companies to tackle stress and anxiety at work.
Semaglutide Compounding Dispute: Novo Nordisk Heads To Court
The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.